R. David Hoover - Nov 30, 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Director
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for R. David Hoover
Stock symbol
ELAN
Transactions as of
Nov 30, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 05:28 PM
Previous filing
Oct 3, 2023
Next filing
Jan 3, 2024
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Remarks:

Chairman of the Elanco Board of Directors